Antacids
Showing 1 - 25 of 123
Heartburn, Dyspepsia, Reflux Trial in Leuven (de-prescription of PPI via intermittent scheme, de-prescription of PPI via
Not yet recruiting
- Heartburn
- +2 more
- de-prescription of PPI via intermittent scheme
- +2 more
-
Leuven, Vlaams Brabant, BelgiumJan Tack
Nov 16, 2022
Radiation-induced Oesophagitis Trial in Austria, Germany (oxetacaine, aluminium and magnesium hydroxide, oxetacaine, magnesium
Terminated
- Radiation-induced Oesophagitis
- oxetacaine, aluminium and magnesium hydroxide
- +3 more
-
Feldkirch, Austria
- +31 more
Feb 4, 2022
Gastro Esophageal Reflux Trial in Nijmegen (No intervention)
Active, not recruiting
- Gastro Esophageal Reflux
- No intervention
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Jan 16, 2023
After Withdrawal of Proton Pump Inhibitor in Geriatric
Completed
- Proton Pump Inhibitor
- Antacids
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Aug 5, 2019
C. Difficile Trial (Arm 1: Routine care, Arm 2: Preemptive C. difficile infection prevention bundle)
Recruiting
- C. Difficile
- Arm 1: Routine care
- Arm 2: Preemptive C. difficile infection prevention bundle
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 23, 2022
Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia
Not yet recruiting
- Tyrosine Kinase Inhibitor
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Feb 17, 2022
GERD Trial in Ho Chi Minh (Thread Embedding Acupuncture, Auricular acupuncture, Standard treatment)
Recruiting
- GERD
- Thread Embedding Acupuncture
- +2 more
-
Ho Chi Minh, VietnamUniversity of Medical Center HCMC - Branch no.3, University of M
Nov 27, 2023
Proton Pump Inhibitor, Inappropriate Drug Use, Discontinuation Trial (Patient Journey App, Information folder)
Not yet recruiting
- Proton Pump Inhibitor
- +3 more
- Patient Journey App
- Information folder
- (no location specified)
Apr 20, 2022
Dyspepsia, Biliary Dysplasia Trial in Korea, Republic of (efficacy and safety of CNU® Capsule)
Completed
- Dyspepsia
- Biliary Dysplasia
- efficacy and safety of CNU® Capsule
-
Seongnam, Bundang-gu, Korea, Republic of
- +5 more
Mar 21, 2022
Chronic Atrophic Gastritis Trial in Beijing (Manpixiao, Active comparator)
Recruiting
- Chronic Atrophic Gastritis
- Manpixiao
- Active comparator
-
Beijing, China
- +2 more
Aug 5, 2022
The Aim of Our Study Was to Evaluate the Outcomes in Women Who Implemented the Enhanced Recovery After Surgery Protocol at
Completed
- The Aim of Our Study Was to Evaluate the Outcomes in Women Who Implemented the Enhanced Recovery After Surgery Protocol at Delivery by Cesarean Delivery
-
Düzce, TurkeyAli Yavuzcan
Apr 23, 2023
Gastroesophageal Reflux Disease Trial (endoloop mediated cardioplication (ECLC) procedure)
Not yet recruiting
- Gastroesophageal Reflux Disease
- endoloop mediated cardioplication (ECLC) procedure
- (no location specified)
Nov 22, 2023
Heart Failure, Hypertension, Pulmonary Trial in Indianapolis, Saint Louis (Beetroot Juice (BRJ), )
Active, not recruiting
- Heart Failure
- Hypertension, Pulmonary
- Beetroot Juice (BRJ)
- placebo
-
Indianapolis, Indiana
- +1 more
Jan 30, 2023
Treatment Pathway in Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
-
Argentina, Argentina
- +17 more
Aug 9, 2022
Active Peptic Ulcer Disease/GI Bleeding Trial in Hongkong (Misoprostol Oral Tablet, Placebo Oral Tablet)
Recruiting
- Active Peptic Ulcer Disease/GI Bleeding
- Misoprostol Oral Tablet
- Placebo Oral Tablet
-
Hongkong, Hong KongEndoscopy Center, Prince of Wales Hospital, Shatin
Feb 3, 2022
Heart Failure Trial in Saint Louis (KNO3, potassium nitrate)
Active, not recruiting
- Heart Failure
- KNO3, potassium nitrate
-
Saint Louis, MissouriWashington University School of Medicine
Feb 22, 2022
Oesophageal Reflux, Gastric Reflux, Hyperactivity; Stomach Trial in Barcelona (Antacid, Control)
Active, not recruiting
- Oesophageal Reflux
- +2 more
- Antacid
- Control
-
Barcelona, SpainOriol Armengol
Aug 1, 2022
Healthy Trial in Leeds (Lu AG06466 Capsule, Lu AG06466 Tablet, Antacid)
Completed
- Healthy
- Lu AG06466 Capsule
- +2 more
-
Leeds, United KingdomLabCorp Clinical Research Unit Ltd
Jan 20, 2022
Antibiotic-induced Disruption of the Microbiota
Recruiting
- Microbiota
- Antibiotic Disruption
- No intervention
-
Fribourg, SwitzerlandHopital cantonal Fribourg
Apr 27, 2021
Chronic Bacterial Prostatitis Trial in Greece, Italy (Prulifloxacin 600 mg, Levofloxacin 500mg)
Completed
- Chronic Bacterial Prostatitis
- Prulifloxacin 600 mg
- Levofloxacin 500mg
-
Athens, Greece
- +10 more
May 12, 2021
Secretin in Refeeding
Not yet recruiting
- Anorexia in Adolescence
- (no location specified)
Feb 1, 2022